Page last updated: 2024-09-03

parecoxib and Constriction, Pathologic

parecoxib has been researched along with Constriction, Pathologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chang, TC; Kiu, KT; Wang, TH; Yen, MH1
Becker, A; Geisslinger, G; Grecksch, G; Höllt, V; Murín, R; Schröder, H; Zimmer, A1

Other Studies

2 other study(ies) available for parecoxib and Constriction, Pathologic

ArticleYear
Comparison of the short-term outcomes of using DST and PPH staplers in the treatment of grade III and IV hemorrhoids.
    Scientific reports, 2020, 03-23, Volume: 10, Issue:1

    Topics: Acetaminophen; Anal Canal; Analgesics; Anus Diseases; Constriction, Pathologic; Equipment Design; Female; Hemorrhage; Hemorrhoidectomy; Hemorrhoids; Humans; Intestinal Mucosa; Isoxazoles; Male; Middle Aged; Organ Size; Pain, Postoperative; Postoperative Complications; Retrospective Studies; Surgical Staplers; Treatment Outcome; Urinary Retention

2020
Cannabinoid-mediated diversity of antinociceptive efficacy of parecoxib in Wistar and Sprague Dawley rats in the chronic constriction injury model of neuropathic pain.
    Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:5

    Topics: Animals; Cannabinoids; Chronic Disease; Constriction, Pathologic; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Female; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuralgia; Pain Measurement; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Cannabinoid, CB1; Sciatic Neuropathy; Species Specificity; Treatment Outcome

2013